Loading...

Loading...

Anti-Obesity Demand Surges Amid Shortages: Pharma's Opportunity
By MBN Staff - Mon, 02/26/2024 - 09:27
Rising demand for anti-obesity drugs meets shortages acknowledged by FDA and EMA—a key opportunity for pharmaceutical manufacturing globally.

https://mexicobusiness.news/tag/pharma
More Health
Made in India: Is Indian Tech an Opportunity for Pharma?
By Deyanira Chiñas - Wed, 01/24/2024 - 09:00
India has the right ingredients — and character — to become a player in the area of original pharmaceutical technology, writes Deyanira Chiñas Ramírez
 Loneliness, AMR, Pharma Distribution: This Week in Health
By Anmol Motwani - Thu, 11/23/2023 - 09:32

The WHO addresses the global loneliness crisis, AMR Awareness Week combats drug resistance, and the pharma industry charts faces profit challenges.

Charting Profitable Waters: The Revolution of Pharma Distribution
By Sandra Sánchez-Oldenhage - Thu, 11/16/2023 - 12:00
Amid distribution tempest, innovative strategies can help pharma set sail toward a resilient and prosperous future, writes Sandra Sánchez-Oldenhage.
Collaborate to Ensure Innovative Drug Availability: Stendhal
By Anmol Motwani - Mon, 10/02/2023 - 09:37
Collaboration is needed to avoid challenges that deter the timely emergence of innovative medicines, says Rodrigo Ruiz of Stendhal Pharma.
Nearshoring in Mexico: The Healthcare and Pharma Opportunity
By Sandra Sánchez-Oldenhage - Thu, 03/09/2023 - 08:45
Mexico can be a formidable alternative to China for pharma manufacturers — if it can manage its drawbacks, writes Sandra Sánchez-Oldenhage.
Telemedicine Beyond Health and Insurance Markets
By Carina Reverter - Mon, 02/13/2023 - 09:00
Telemedicine has been proven to be successful within the health and insurance industries and it continues to grow, writes Carina Reverter.
Pharma Omnichannel: An Enhanced Personalized Customer Experience
By Sandra Sánchez-Oldenhage - Thu, 12/01/2022 - 11:00
Without an omnichannel mindset, you may be missing out on crucial opportunities to improve brand experience, writes Sandra Sanchez-Oldenhage.
ESG for Pharma: Fad or Megatrend?
By Sandra Sánchez-Oldenhage - Fri, 08/26/2022 - 09:00
ESG is a business fundamental and should not be viewed as a mandatory requirement or the right thing to do, writes Sandra Sánchez-Oldenhage.
The Pharma E-Commerce Opportunity: What It Takes to Win
By Sandra Sánchez-Oldenhage - Fri, 05/20/2022 - 09:00
Optimizing the pharma business model by offering e-commerce options in this digital era is simply smart business, writes Sandra Sánchez-Oldenhage.